TMAO compound may play role in cardiovascular disease risk

04/26/2013 | WebMD

Individuals with the highest levels of trimethylamine-N-oxide, a compound produced in the stomach, were 2.5 times more likely to suffer a heart attack, stroke or heart disease than those with the lowest TMAO levels, a study showed. The compound can make it more difficult for the liver and intestines to remove cholesterol, lead researcher Dr. Stanley Hazen of the Cleveland Clinic said. The findings were published in the New England Journal of Medicine.

View Full Article in:

WebMD

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC